# OnCo record z-alpha-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/z-alpha-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "z-alpha-therapeutics" ;
  schema:name "Z-Alpha Therapeutics"@en ;
  schema:alternateName "Z-Alpha"@en ;
  schema:description "Z-Alpha Therapeutics, in San Diego, is developing cancer drugs that carry a radioactive atom, astatine-211, to tumour cells to destroy them from close range. Its first drug, for prostate cancer, has had an early study in China."@en ;
  schema:url <https://onco.cc/companies/z-alpha-therapeutics/>, <https://z-alpha.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://z-alpha.com/>, <https://view.asiae.co.kr/en/article/2026020909521368429>, <https://www.orbimed.com/portfolio/> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/astatine-211-alpha-therapy/>, <https://onco.cc/technologies/targeted-alpha-therapy/> .